1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- Becton, Dickinson and Co.
- Carestream Health Inc.
- Danaher Corp.
- FUJIFILM Holdings Corp.
- General Electric Co.
- Hologic Inc.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Breast Biopsy Devices Market: About this market
The breast biopsy devices market analysis considers sales from biopsy needles and systems, biopsy image-guided systems, and other products. Our analysis report also considers finds the sales of breast biopsy devices in Asia, Europe, North America, and ROW. In 2018, the biopsy needles and systems segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the reduced technical complexities associated with biopsy needles and systems will play a significant role in the biopsy needles and systems segment to maintain its market position. Also, our global breast biopsy devices market report looks at factors such as the growing prevalence of breast cancer cases and an increasing number of products showcasing and approvals. However, high cost of breast biopsy, presence of alternative non-invasive procedures, and complications associated with breast biopsy and lack of trained professionals may hamper the growth of the breast biopsy devices industry over the forecast period.
Global Breast Biopsy Devices Market: Overview
Growing prevalence of breast cancer cases
Breast cancer is a deadly health condition and prevalent in women across the world. Even young women have a higher risk of developing breast cancer if they have a genetic propensity for ovarian and breast cancer or if there is a mutation in their BRCAI and BRCA2 gene. This is driving the need to create awareness and treat the patients after a proper analysis. Professionals are gathering a wide range of accumulative data and establishing facilities to encourage patients to undergo screening and diagnosis. This will boost the demand for breast biopsy procedures in various healthcare units. This growing prevalence of breast cancer cases will lead to the expansion of the global breast biopsy devices market at a CAGR of over 10% during the forecast period.
Paradigm shift toward the adoption of breast biopsy robot systems
There is an increase in the demand for technologically advanced breast biopsy devices comprising of robotic platforms, artificial intelligence, and surgical navigation systems. This is due to the growing demand need for minimally invasive procedures and accurate accurate and efficient surgical procedures. Vendors are focusing on improving the healthcare outcomes by developing technological solutions integrated with AI. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global breast biopsy devices market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading breast biopsy devices manufacturers, that include Argon Medical Devices Inc., Becton, Dickinson and Co., Carestream Health Inc., Danaher Corp., FUJIFILM Holdings Corp., General Electric Co., Hologic Inc., Planmed Oy, Scion Medical Technologies LLC, and Siemens Healthineers AG.
Also, the breast biopsy devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming future growth opportunities.
The breast biopsy devices market analysis considers sales from biopsy needles and systems, biopsy image-guided systems, and other products. Our analysis report also considers finds the sales of breast biopsy devices in Asia, Europe, North America, and ROW. In 2018, the biopsy needles and systems segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the reduced technical complexities associated with biopsy needles and systems will play a significant role in the biopsy needles and systems segment to maintain its market position. Also, our global breast biopsy devices market report looks at factors such as the growing prevalence of breast cancer cases and an increasing number of products showcasing and approvals. However, high cost of breast biopsy, presence of alternative non-invasive procedures, and complications associated with breast biopsy and lack of trained professionals may hamper the growth of the breast biopsy devices industry over the forecast period.
Global Breast Biopsy Devices Market: Overview
Growing prevalence of breast cancer cases
Breast cancer is a deadly health condition and prevalent in women across the world. Even young women have a higher risk of developing breast cancer if they have a genetic propensity for ovarian and breast cancer or if there is a mutation in their BRCAI and BRCA2 gene. This is driving the need to create awareness and treat the patients after a proper analysis. Professionals are gathering a wide range of accumulative data and establishing facilities to encourage patients to undergo screening and diagnosis. This will boost the demand for breast biopsy procedures in various healthcare units. This growing prevalence of breast cancer cases will lead to the expansion of the global breast biopsy devices market at a CAGR of over 10% during the forecast period.
Paradigm shift toward the adoption of breast biopsy robot systems
There is an increase in the demand for technologically advanced breast biopsy devices comprising of robotic platforms, artificial intelligence, and surgical navigation systems. This is due to the growing demand need for minimally invasive procedures and accurate accurate and efficient surgical procedures. Vendors are focusing on improving the healthcare outcomes by developing technological solutions integrated with AI. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global breast biopsy devices market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading breast biopsy devices manufacturers, that include Argon Medical Devices Inc., Becton, Dickinson and Co., Carestream Health Inc., Danaher Corp., FUJIFILM Holdings Corp., General Electric Co., Hologic Inc., Planmed Oy, Scion Medical Technologies LLC, and Siemens Healthineers AG.
Also, the breast biopsy devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming future growth opportunities.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Becton, Dickinson and Co.
- Carestream Health Inc.
- Danaher Corp.
- FUJIFILM Holdings Corp.
- General Electric Co.
- Hologic Inc.
PART 01: EXECUTIVE SUMMARYPART 08: CUSTOMER LANDSCAPEPART 11: DECISION FRAMEWORKPART 13: MARKET TRENDS
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 07: MARKET SEGMENTATION BY MODALITY
PART 09: MARKET SEGMENTATION BY END-USER
PART 10: GEOGRAPHIC LANDSCAPE
PART 12: DRIVERS AND CHALLENGES
PART 14: VENDOR LANDSCAPE
PART 15: VENDOR ANALYSIS
PART 16: APPENDIX
List of Exhibits
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Becton, Dickinson and Co.
- Carestream Health Inc.
- Danaher Corp.
- FUJIFILM Holdings Corp.
- General Electric Co.
- Hologic Inc.
The following companies are recognised as the key players in the global breast biopsy devices market: Argon Medical Devices Inc., Becton, Dickinson and Co., Carestream Health Inc., Danaher Corp., FUJIFILM Holdings Corp., General Electric Co., Hologic Inc., Planmed Oy, Scion Medical Technologies LLC, and Siemens Healthineers AG.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the paradigm shift toward adoption of breast biopsy robot systems.”
According to the report, one of the major drivers for this market is the growing prevalence of breast cancer cases.
Further, the report states that one of the major factors hindering the growth of this market is the complications associated with breast biopsy and lack of trained professionals.
The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the paradigm shift toward adoption of breast biopsy robot systems.”
According to the report, one of the major drivers for this market is the growing prevalence of breast cancer cases.
Further, the report states that one of the major factors hindering the growth of this market is the complications associated with breast biopsy and lack of trained professionals.
The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Argon Medical Devices, Inc.
- Becton, Dickinson and Co.
- Carestream Health Inc.
- Danaher Corp.
- FUJIFILM Holdings Corp.
- General Electric Co.
- Hologic Inc.
- Planmed Oy
- Scion Medical Technologies LLC
- Siemens Healthineers AG
Note: Product cover images may vary from those shown